

Announcements.

Looking to discover a little more about our client companies?
A selection of news and recent announcements can be found here.
Dev Clever Holdings : Engage update
RNS Number : 8491A Dev Clever Holdings PLC 03 June 2019 Dev Clever Holdings plc ("Dev Clever" or "the Company") Engage: Activity Update Dev Clever, a leading developer of consumer engagement experiences, announced the launch of its new productised cloud-based gamification platform "Engage" on 6 March 2019. Within the……
RNS Number : 8491A
Dev Clever Holdings PLC
03 June 2019
Dev Clever Holdings plc
("Dev Clever" or "the Company")
Engage: Activity Update
Dev Clever, a leading developer of consumer engagement experiences, announced the launch of its new productised cloud-based gamification platform "Engage" on 6 March 2019. Within the first 12 weeks, Dev Clever has already successfully delivered gamification campaigns for the following national retailers, global companies and blue-chip brands.
· Pepsi MAX (instant win game)
· J20 (snapchat instant win game)
· Bosch (skill based game)
· Jewson (skill based game to win daily prizes)
· R Whites (instant win game)
· Mortimer's Cider (skill based game)
· Stowford Press Cider (instant win game)
· Swinton Insurance (skill-based game)
· Oracle (Live sports stadium loyalty demonstration)
Engage is a proprietary, cloud-based consumer engagement platform which uses gamification to enable brands and retailers to incentivise consumers to purchase products and generate additional sales by rewarding the consumer with a chance to win high value prizes and digital discount vouchers which are instantly redeemable in stores and venues that are part of our partner network. The consumer has a chance to win these incentives by playing a game via their mobile device immediately on completion of their product purchase or qualifying action.
Games range from instant win mechanics and skill-based games to gamified digital loyalty cards. Using gamification to offer higher value prizes and incentives, brands and retailers can attract more consumers to their incentives and drive more product sales through a seamless digital consumer experience offer via the Engage platform. The gamification engine acts as a control mechanism to manage the exact number of prizes and vouchers given away, eliminating the risk of a brand or retailer over spending on over redemption.
In addition to delivering successful activations for brands and retail customers in the UK, Dev Clever is also in advanced conversations with new commercial partners which, once finalised, will increase the reach of Engage in the retail, education and hospitality sectors throughout the UK as well as provide a network to deliver brand marketing campaigns to customers across Europe, America and the UAE.
Chris Jeffries CEO said: "It has been a very busy 12 weeks since we launched the Engage cloud-based platform. The feedback from our customers has been tremendous and we have seen a positive uplift in our sales and order book since its launch. The new partnerships we aim to introduce shortly will unlock significant opportunities for the growth of Engage, not just in the UK but across the world. That said, we are firmly focused on our short-term UK objectives and we are still increasing our headcount each month to keep up with demand."
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
NRACKBDBDBKBDAK
CloseImmotion Group PLC : Content and Licensing Update
RNS Number : 3400Z Immotion Group PLC 17 May 2019 THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE EU MARKET ABUSE REGULATION (596/2014). UPON THE PUBLICATION OF THE ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE……
RNS Number : 3400Z
Immotion Group PLC
17 May 2019
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE EU MARKET ABUSE REGULATION (596/2014). UPON THE PUBLICATION OF THE ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
Immotion Group plc
("Immotion Group", the "Company")
Content and Licensing Update
Immotion Group, the UK-based immersive virtual reality ("VR") 'Out of Home' entertainment group, is pleased to announce the signing of a circa $500,000 VR and immersive content creation contract with global family entertainment specialist, iP2Entertainment, based in Amsterdam.
Immotion Group is focused on establishing itself as a global leader in high quality VR content creation, including a number of proprietary experiences currently operating on its motion platforms, and now being licensed to third party platforms.
This new contract will see Immotion Group producing three exclusive VR and immersive experiences for IP2Entertainment. These experiences will be available for iP2Entertainment centres' visitors later this year and into 2020. All work is scheduled to be completed by November 2019.
This collaborative partnership will add significant benefit to both organisations, allowing Immotion Group to develop these experiences for iP2Entertainment and providing Immotion with access to them for non-competing uses.
iP2Entertainment is a renowned family entertainment company building immersive indoor family entertainment centres all around the globe for a number of world-famous brands, including National Geographic and DreamWorks to name but a few. iP2's mission is to immerse families into the worlds of the brands and characters they know and love through innovative, memorable, and exciting experiences designed to entertain as well as educate through play and fun.
Martin Higginson, Group CEO, Immotion Group, commented:
"iP2Entertainment are well recognised as being one of the leading players in the 'out of home' immersive entertainment space. Having the opportunity to work with them in the creation of some cutting-edge VR experiences will not only deliver valuable revenue for the studio but also help us further develop and showcase our skill set in this exciting market, whilst providing access to some exciting new content."
Ian Liddell, Group Creative Director, Immotion Group, commented:
"Our studio has always been synonymous with the origination of high-quality content for many platforms. The considerable knowledge and experience we have gained creating proprietary VR experiences has quickly established us as one of the leading originators in the Global VR market. Within that period, we have had numerous requests to create and license content."
"Working with Global entertainment specialists, iP2Entertainment, in the development of some exciting immersive experiences will help us further hone and showcase our skills."
Roger Houben, co-founder and CEO of iP2, commented:
"We are very pleased to have Ian and his team on board for the creation of several immersive media experiences for our family entertainment centres. Immotion is recognised as one of the best in the world in the creation of top-quality immersive media content productions. We look very much forward to working with them on this prestigious project. Hopefully the start of a long and mutually beneficial relationship."
Enquiries:
|
Immotion Group |
Martin Higginson |
Tel: +44 (0) 161 235 8505 |
|
WH Ireland Limited (Nomad and Joint Broker) |
Adrian Hadden Jessica Cave
|
Tel: +44 (0) 207 220 1666 |
|
Newgate Communications (Financial PR) |
Elisabeth Cowell Robin Tozer
|
Tel: +44 (0) 20 3757 6880 |
|
|
|
|
|
|
|
|
|
|
|
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
CNTDBGDULBBBGCL
CloseOsirium Technologies : Contract Extension
RNS Number : 3327Z Osirium Technologies PLC 17 May 2019 17 May 2019 Osirium Technologies plc ("Osirium" or "Group") Contract extension with leading global asset management company Commitment for a three year global Privileged Access Management (PAM) project Osirium Technologies plc (AIM:……
RNS Number : 3327Z
Osirium Technologies PLC
17 May 2019
17 May 2019
Osirium Technologies plc
("Osirium" or "Group")
Contract extension with leading global asset management company
Commitment for a three year global Privileged Access Management (PAM) project
Osirium Technologies plc (AIM: OSI.L), a leading vendor of cloud-based cybersecurity software, is pleased to announce a significant three year contract extension with a leading global asset manager. The customer which has over £300 billion of assets under management and offices in c.30 countries has expanded its subscription for 3,000 to 4,500 devices.
The contract will be booked in the current financial year with revenue being released over the three year term. Under the terms of the contract, Osirium will deliver its full PxM product offering.
David Guyatt, Chief Executive Officer, commented: "We are delighted to have received this order which validates our 'land and expand' strategy. The fact that this customer has expanded its license from 3,000 to 4,500 devices shows that Osirium's technology is at the heart of their strategy for maximising security and demonstrating rigorous compliance. The customer has also renewed their 24/7 support arrangement with Osirium which testifies to the excellent quality of service we offer them."
– Ends –
For further information:
|
Osirium Technologies plc |
Tel: +44 (0) 118 324 2444 |
|
David Guyatt, Chief Executive Officer Rupert Hutton, Chief Financial Officer
|
|
|
Stifel Nicolaus Europe Limited (Nominated Adviser and Broker) |
Tel: +44 (0) 20 7710 7600 |
|
Fred Walsh / Neil Shah / Alex Price
|
|
|
Yellow Jersey PR (Financial PR) Sarah Hollins Henry Wilkinson |
Tel: +44 (0)7764 947 137 Tel: +44 (0)7951 402 336
|
Notes to Editors:
About Osirium
Osirium Technologies plc (AIM: OSI.L) operates in one of the fastest growing parts of the cybersecurity market and is a leading vendor of Privileged Access Management ("PAM") software. Osirium's cloud-based products protect critical IT assets, infrastructure and devices by preventing targeted cyber-attacks from directly accessing Privileged Accounts, removing unnecessary access and powers of Privileged Account users, deterring legitimate Privileged Account users from abusing their roles and containing the effects of a breach if one does happen.
Osirium has defined and delivered what the Directors view as the next generation PAM solution. The team has developed the concept of a Virtual Air Gap to separate users from passwords. Built on Robotic Automation technology, Osirium's Privileged Task Management module further strengthens Privileged Account security by minimising the cyber-attack surface and delivering an impressive return on investment benefits for customers.
Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to AIM in April 2016. For further information please visit www.osirium.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
CNTAFMFTMBIBBTL
CloseVerditek PLC : Complete control of Solar PV Business
RNS Number : 3874Z Verditek PLC 17 May 2019 Amendments have been made to the announcement (3325Z), released 17 May 2019, in the title and the third paragraph of the body of the text. All other details remain unchanged. Verditek PLC ("Verditek" or the "Company") Verditek takes……
RNS Number : 3874Z
Verditek PLC
17 May 2019
Amendments have been made to the announcement (3325Z), released 17 May 2019, in the title and the third paragraph of the body of the text. All other details remain unchanged.
Verditek PLC
("Verditek" or the "Company")
Verditek takes complete control of Solar PV Business
Verditek plc, (AIM: VDTK) is pleased to announce that it has successfully negotiated complete control of Greenflex Energy Limited (previously a 51% subsidiary of Verditek plc), and liquidated Greenflex RSM s.r.l.
In doing so Verditek has consolidated all our PV assets in Verditek Solar Italy which will benefit from 100% of the results going forward. The acquisition has been achieved with complete cooperation of the minority interest holder, forgiving accumulated losses incurred in Greenflex RSM s.r.l, the asset holding company owned entirely by Greenflex Energy Limited. The consolidated accounts of Verditek plc will reflect this change and full ownership of all assets of Verditek Solar Italy.
Having complete control of the company and assets has allowed Verditek Solar Italy s.r.l. to move forward quickly with refurbishing the Lainate manufacturing facilities and refining the formulation of our lightweight PV modules. The result is a novel solar PV product that is significantly lighter and easier to install than conventional panels. This opens up new market opportunities with clients who could not consider a solar solution due to the weight and installation challenges of conventional panels. Additionally, Verditek has been developing financial instruments to offer clients the opportunity to reduce or remove the initial capital burden incurred with installing solar on their premises. By partnering with EPC (Engineering, Procurement, Construction) companies, and investors, we can create an affordable entry into solar and attract investment into renewable energy developments.
Dr Geoff Nesbitt, CEO of Verditek plc said: "the acquisition of the minority interest in Greenflex Energy and liquidation of Greenflex RSM allows us to operate decisively. A tremendous amount of work and commitment has been invested to turn this facility around and it will be gratifying to benefit fully from our efforts. We will continue to open up market opportunities via smart partnering with other organizations aligned to bring Solar PV to clients that would otherwise be denied access to renewable energy."
About Verditek:
Verditek plc (AIM: VDTK), the clean technology company is headquartered in London. Verditek is dedicated to commercializing proven technology in the renewable energy and clean-tech sectors that can deliver significant competitive advantage compared to conventional industrial solutions. With particular focus on light-weight solar modules, Verditek also has interests in cutting edge de-odorization and ground-breaking CO2 capture. Verditek is realising tomorrow's technologies today.
For further information, please visit www.verditek.com
Enquiries:
|
Verditek plc Geoffrey Nesbitt, CEO Verditek Solar Italy srl Alfredo De Mutiis, Managing Director |
Tel: +44 (0)78 3306 2577 |
|
WH Ireland Limited – NOMAD and Broker |
Tel: +44 (0)20 7220 1666 |
|
Chris Hardie Matthew Chan |
|
|
|
|
|
Strand Hanson Limited – Financial Adviser James Harris Ritchie Balmer Jack Botros |
Tel: +44 (0)20 7409 3494 |
The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
MSCEAXSXFEANEEF
CloseIntegumen PLC : Launch of Labskin human skin clone tests
RNS Number : 6976Y Integumen PLC 10 May 2019 AIM share code: SKIN Integumen PLC ("Integumen" or "Company") Launch of Labskin human skin clone tests for Medical Device and Clinical Research trials Combined with human volunteers doubles number of skin tests possible saving time and money……
RNS Number : 6976Y
Integumen PLC
10 May 2019
AIM share code: SKIN
Integumen PLC
("Integumen" or "Company")
Launch of Labskin human skin clone tests for Medical Device and Clinical Research trials
Combined with human volunteers doubles number of skin tests possible saving time and money
Integumen today announces the roll-out of the Labskin human clone skin testing platform into the medical device and clinical research sectors.
When combined with human volunteers, Labskin's AI platform creates double the number of skin tests possible that are more reliable and accurate than human volunteers alone. The Labskin test process transforms the cost structures of medical device and skin treatment clinical trial testing by:
· 50% reduction of human volunteers required for each trial;
· Instantly creates a cloned twin of the human test subject;
· Reduces recruitment time;
· Cuts project management costs, supervision time and support personnel by up to 50%;
· AI integration delivers reliable comparative analytical data plus human test response data;
· Lowers error rate by reducing number of human volunteers who are not sticking to test regime;
· Increases scientific accuracy and anecdotal evidence from human clone twin tests;
· Real-time feedback through the Labskin AI platform to client; which,
· Delivers fast results, lowers development costs and reduces time to market
The Integumen business model of collaboration with the Centre for Skin Sciences (CSS) in Bradford, UK, Sheffield Hallam University, UK, Cork Institute of Technology, Ireland, plus Integumen's own enlarged Labskin laboratories in York, UK, provides access to thousands of potential student volunteers with all sorts of skin diseases, reducing the recruitment process for specific young adult prone skin diseases.
Gerard Brandon, CEO of Integumen plc, comments:
"Regulatory pressures have increased the demand for skin testing in EU 2017/745 rule 21 and animal testing is now banned on skin related products in EU Directive 2003/15/EC enforced since March 2013. As a trusted partner to our CRO (Contract Research Organisation) partners, our disruptive technology is able to enhance the margins of medical device and clinical trial organisations on test subjects. Labskin can double the output of test results requiring fewer test volunteers and lower project management time, delivering faster, more reliable and consistent results for their skin care, health care, wound care and pharmaceutical clients, all at a lower cost to our partners."
Contacts
|
Integumen plc |
Gerard Brandon, CEO
|
+44 (0) 7340 055 643 |
|
SPARK Advisory Partners Limited (Nominated Adviser)
|
Neil Baldwin/Andrew Emmott |
+44 (0) 113 370 8974 |
|
Turner Pope Investments (TPI) Limited (Broker) |
Andy Thacker |
+44 (0) 20 3621 4120 |
About Integumen:
Integumen is a vertically integrated business, collaborating their Labskin technology platform with partners in artificial intelligence, clinical research, medical device and life science. These collaborators are building their own technology on top of the Labskin AI backbone. Labskin allows skin-care, health-care, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies.
The Company combines data analytics with access to therapeutic operational expertise and offers solutions to our clients, from regulatory approvals, right through to marketing fully tested ingredients that have been certified on our Laboratory grown living human tissue.
About RNS Reach announcements:
RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
NRASFEFFSFUSESI
CloseSativa Investments : Goodbody & Blunt wellness centre to open in Bath
RNS Number : 8735X Sativa Investments PLC 02 May 2019 Press Release 2 May 2019 The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the……
RNS Number : 8735X
Sativa Investments PLC
02 May 2019
|
Press Release
|
2 May 2019 |
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.
Sativa Investments PLC
("Sativa" or "the Company" or "the Group")
Sativa to open first Goodbody & Blunt wellness centre in Bath with lease signed
Sativa Investments PLC (NEX: SATI), the UK's first medicinal cannabis investment vehicle, is to open the first of its Goodbody & Blunt wellness centres in Bath and has leased a 60.67 sq. m (653 sq. ft) retail unit with frontage on to the prime, high footfall, Broad Street and Milson Place City-centre shopping destinations.
The store will offer a wide range of Cannabidiol ("CBD") products and will include a café for customers to consume CBD infused coffee, tea and water. Customers will also be able to buy CBD sport's energy shots and also specially selected CBD coffee and tea in bean form to take home and enjoy in their own environment.
The UK is fast-recognising, along with North America and much of Europe, CBD as a valuable alternative medicine and treatment. Sativa already has a well-established on-line and wholesale brand, George Botanicals, which has developed bespoke white label products for Goodbody & Blunt. The store will also stock high quality CBD products from around the world. Every item stocked by the Goodbody & Blunt stores will have passed rigorous industry-leading tests, conducted by Sativa's own PhytoVista Laboratories which analyses the quality and the levels of the CBD compound contained within products, both for its own sales and also third parties. That analysis ensures that every stock item achieves full compliance within regulatory limits.
The Bath store is the first of three pilot stores after which the Company intends to roll-out a national franchise network, because the Directors believe that this is the fastest and least capital-intensive route to a national footprint. The Company feels a direct consumer relationship is very important in order to support its future franchisees and brand development.
As announced in January 2019, the Goodbody & Blunt initiative is led by Chris Jones, a recognised retail expert whose experience includes the early deployment of the Phones 4U retail presence.
In tandem with the launch of the Goodbody & Blunt chain, the Company is working closely with the Food Standards Authority (FSA) as it deliberates how to regulate CBD products, an initiative that Sativa welcomes and is delighted to assist in.
Geremy Thomas, Chief Executive and founder, said: "Sativa was first to market as a UK-quoted medical cannabis investment vehicle and continues to lead the way with its seed to consumer strategy. Goodbody & Blunt's high-street CBD outlets will break with tradition, delivering high-end wellness centres with fully trained staff to advise on the quality and provenance of products.
"Key value drivers to Sativa's business model include brand recognition and distribution, and the Goodbody & Blunt initiative provides both, alongside the Group's other brands of George Botanicals and PhytoVista laboratories.
"Sativa is a full-spectrum Group of businesses within the medicinal cannabis and CBD industries, offering in-house validated testing alongside retail, and is progressing well with an R&D Home Office licence application that will facilitate the Company supplying Kings' College London with medicinal cannabis research product from its secure growing facility."
The Bath store is expected to open in early summer 2019.
The Directors of the Company accept responsibility for the contents of this announcement.
– Ends –
For further information please contact:
|
Geremy Thomas Founder & Chief Executive Officer Sativa Investments PLC +44 (0) 20 7971 1255 |
Joseph Colliver Chief Financial Officer Sativa Investments PLC +44 (0) 20 7971 1255 |
|
NEX Exchange Corporate Adviser Guy Miller and Lucy Williams Peterhouse Capital Limited +44 (0) 20 7469 0930 |
|
|
Financial PR and IR Abchurch Communications Julian Bosdet
Abchurch Switchboard |
+44 (0) 20 7469 4630 |
Notes to Editors
Sativa invests in well-placed ventures within the dynamic regulatory environment of the Medicinal Cannabis sector. The Company's pan-European, end-to-end, seed-to-consumer investment strategy focuses on the production, testing and compliance, research and development, including pharmacology, commercialisation and sales and marketing of Medicinal Cannabis in jurisdictions where it is regulatorily permitted. Sativa has committed to an independent legal review prior to each investment to verify compliance with the prevailing regulatory environment.
The Company's equity interest in an investment may range from a minority position, to a controlling interest, or to 100 per cent ownership. The ventures that Sativa acquires can either be public or private.
Sativa Investments has already made six investments to date, these being Canada-based and dual-listed emerging pharmaceutical company, Veritas Pharma Inc. ("Veritas Pharma" or "Veritas"), CSE-listed Toronto-based Pharma-Tech company Rapid Dose Therapeutics Inc. ("RDT"), which owns the patent-pending proprietary QuickStrip™ technology, UK-based CBD products provider George Botanicals Ltd (of which Sativa has 100 per cent ownership), PhytoVista Laboratories (of which Sativa also has 100 per cent ownership), a UK testing laboratory meeting the need for regulatory and batch testing of products such as CBD oil, a joint venture with Germany's Lexamed GmbH, and an option on a 7.53-acre development site in Wiltshire with the potential to build a glasshouse for growing raw cannabis for medicinal and CBD use.
Sativa is also focussed on researching and developing medicinal cannabis products by funding university research grants of medicinal cannabis through its Sativa Foundation.
The Company's Board and Medicinal Cannabis Advisory Board have a combined 60 years' industry experience, with significant pharmaceutical strength and experience and extensive contacts in the industry, which includes pharmacologist Sir Alasdair Breckenridge, who liaises with the Home Office and the Medicines and Healthcare products Regulatory Agency, which he has chaired, for the legalisation of medicinal cannabis in the UK Their extensive skills range from capital fund raisings, medical research, and start-ups, to pharmaceutical development.
For more information on Sativa Investments, please visit: www.sativainvestments.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
NEXGRGDUBUGBGCD
CloseOsirium Technologies : Launch of secure IT Process Automation solution
RNS Number : 6537X Osirium Technologies PLC 01 May 2019 For immediate release 1 May 2019 Osirium Technologies plc ("Osirium" or "Group") Opus sets new benchmark in Privileged IT Process Automation Osirium launches first secure solution to automate key IT processes and increase……
RNS Number : 6537X
Osirium Technologies PLC
01 May 2019
For immediate release
1 May 2019
Osirium Technologies plc
("Osirium" or "Group")
Opus sets new benchmark in Privileged IT Process Automation
Osirium launches first secure solution to automate key IT processes and increase IT Service Desk productivity, while also improving corporate security
Osirium Technologies plc (AIM: OSI.L), a leading vendor of cloud-based cybersecurity software, today announces the immediate availability of Opus, its secure IT Process Automation solution.
Opus builds on Osirium's proven success in Privileged Task Automation, providing a highly-flexible platform for automating essential IT processes. The product has been designed to address currently unresolved challenges of overloaded IT teams, growing backlogs of customer requests and increasing needs to improve security.
David Guyatt, Chief Executive Officer of Osirium commented: "Traditional ways of automating IT processes are inflexible, risky and not fit for the security-conscious 21st century IT organisation. IT Operations teams need a much better alternative, built from the ground-up to be fully secure and integrated for simple deployment and rapid speed to value. They want the benefits of Robotic Process Automation, but with enterprise-grade security. Opus delivers this by automating processes and controlling access to privileged accounts, addressing one of most critical enterprise security challenges facing CISOs, to remove uneccessary direct access to vulnerable privileged accounts.
"Initial customer projects are focusing on IT Help Desks, principally transforming first call resolution performance by delegating help desk automation tasks to first line support teams – a practice now known as "shift-left" operations. Looking further ahead, Osirium sees clear scope for automating additional process-driven environments, such as NetOps, DevOps and IoT.
"The Directors believe that the Opus product will contribute to a growing and material impact on Osirium's financial performance."
– Ends –
For further information:
|
Osirium Technologies plc |
Tel: +44 (0) 118 324 2444 |
|
David Guyatt, Chief Executive Officer Rupert Hutton, Chief Financial Officer
|
|
|
Stifel Nicolaus Europe Limited (Nominated Adviser and Broker) |
Tel: +44 (0) 20 7710 7600 |
|
Fred Walsh / Neil Shah / Alex Price
|
|
|
Yellow Jersey PR (Financial PR) Sarah Hollins Henry Wilkinson |
Tel: +44 (0)7764 947 137 Tel: +44 (0)7951 402 336
|
Notes to Editors:
About Osirium
Osirium Technologies plc (AIM: OSI.L) operates in one of the fastest growing parts of the cybersecurity market and is a leading vendor of Privileged Access Management ("PAM") software. Osirium's cloud-based products protect critical IT assets, infrastructure and devices by preventing targeted cyber-attacks from directly accessing Privileged Accounts, removing unnecessary access and powers of Privileged Account users, deterring legitimate Privileged Account users from abusing their roles and containing the effects of a breach if one does happen.
Osirium has defined and delivered what the Directors view as the next generation PAM solution. The team has developed the concept of a Virtual Air Gap to separate users from passwords. Built on Robotic Automation technology, Osirium's Privileged Task Management module further strengthens Privileged Account security by minimising the cyber-attack surface and delivering an impressive return on investment benefits for customers.
Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to AIM in April 2016. For further information please visit www.osirium.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
MSCKMGFDRGVGLZM
CloseIntegumen PLC : Launch of New Animal-Free Labskin Dandruff Test
RNS Number : 0095X Integumen PLC 25 April 2019 AIM share code: SKIN 25 April 2019 Integumen PLC ("Integumen" or "Company") Launch of New Animal-Free Labskin Dandruff Test Labskin STOER study demonstrates 54% increase in skin rehydration in 24 hours Promotion of new skin cells leaving fresher……
RNS Number : 0095X
Integumen PLC
25 April 2019
AIM share code: SKIN
25 April 2019
Integumen PLC
("Integumen" or "Company")
Launch of New Animal-Free Labskin Dandruff Test
Labskin STOER study demonstrates 54% increase in skin rehydration in 24 hours
Promotion of new skin cells leaving fresher looking skin
Integumen today announces the completion of development and launch of a new dandruff test on its animal-free Labskin test platform. The Company also reports additional successful results of research assessing the impact of STOER products on rehydration of the skin.
Unique Animal-Free Anti-Dandruff testing:
The new Labskin test uses a unique scalp variation that mimics skin bacteria and dandruff, in both healthy and 'itchy' states. This allows for dandruff relief and scalp protection products to be tested effectively on a realistic human skin model in a laboratory setting without the need to test on animals.
Labskin full thickness human skin equivalent is suitable for testing irritation under guideline 439 of the OECD* (see below). Populating and growing bacteria, sourced from human scalp, onto Labskin, clearly demonstrates the effective response of the irritation and hydration tests.
STEOR For Men Serum Labskin tests improves skin hydration
Labskin treated with STOER Serum demonstrated a 54% increase in skin hydration after 24 hours and 22% higher after 48 hours. This effect was seen in the lower layers of the epidermis and at the junction with the dermis, not just the surface. The depth of hydration seen in results of this study validate the long-term effects of using the STOER Serum.
STEOR Power Mask Labskin test packs a punch
The hydration of Labskin treated with STOER Power Mask was 63% higher after 24 hours and 34% higher after 48 hours. As with the STOER Serum, this effect was seen in the lower layers of the epidermis and at the junction with the dermis, not just the surface, demonstrating a long-lasting effect on the skin.
Gerard Brandon, Chief Executive Officer, commented:
"Integumen's strategy is to provide a unique animal-free skin testing platform to test and validate product effects in the pharma, healthcare and beauty industries. Since the beginning of the year, Labskin has demonstrated the ability to substantiate accurate skin care product claims beyond the usual 74% of women or men. We work with our skin care partners who are constantly looking for that competitive edge, to prove the impact of their product claims while maintaining an ethical product on the market.
"Our new Labskin dandruff scalp test not only provides a human skin model in a laboratory setting without the need to test on animals but opens the door to the global hair care market which is expected to reach USD $110.70 Billion by 2024*."
* OECD Guidelines for the Testing of Chemicals are a set of internationally accepted specifications for the testing of chemicals decided on by the Organisation for Economic Co-operation and Development. They were first published in 1981.
|
Integumen plc |
Gerard Brandon, CEO
|
+44 (0) 7340 055 643 |
|
SPARK Advisory Partners Limited (Nominated Adviser)
|
Neil Baldwin/Andrew Emmott |
+44 (0) 113 370 8974 |
|
Turner Pope Investments (TPI) Limited (Broker) |
Andy Thacker |
+44 (0) 20 3621 4120 |
About Integumen:
Integumen is a vertically integrated business, collaborating their Labskin technology platform with partners in artificial intelligence, clinical research, medical device and life science. These collaborators are building their own technology on top of the Labskin AI backbone. Labskin allows skin-care, health-care, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies.
The Company combines data analytics with access to therapeutic operational expertise and offers solutions to our clients, from regulatory approvals, right through to marketing fully tested ingredients that have been certified on our Laboratory grown living human tissue.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
NRAIIMFTMBJTBLL
ClosePowerhouse Enrgy Grp : First Revenue Contract for PowerHouse Energy
PowerHouse Energy Group plc ("PowerHouse Energy" or the "Company") 17 April 2019 First Revenue Contract for PowerHouse Energy PowerHouse Energy Group plc (AIM: PHE), the UK technology company pioneering hydrogen and clean energy production from waste plastic, is pleased to announce that it has signed a binding contract with its……
PowerHouse Energy Group plc
("PowerHouse Energy" or the "Company")
17 April 2019
First Revenue Contract for PowerHouse Energy
PowerHouse Energy Group plc (AIM: PHE), the UK technology company pioneering hydrogen and clean energy production from waste plastic, is pleased to announce that it has signed a binding contract with its exclusive partner, Waste2Tricity Limited (???W2T???), for PHE to provide planning and engineering design services that will, subject to successful outcome, lead to a build contract and license for use of the DMG?? Technology at the Protos site. The agreement defines the paid scope of works during two stages of planning and engineering. At signature, based on quotations from potential Contractors PHE provisionally anticipates that total revenue from the two stages of the contract will amount to approximately ??400,000 to cover PHE and Contractors costs.
The engineering design services to be provided by PHE for stage one includes specific feedstock analysis and testing including some third party services, site modelling and specific engineering related to the Protos site. This work will define the parameters for the second stage of the project, the Front End Engineering Design (FEED) contract which it is anticipated will be placed with an Engineering, Procurement & Construction (EPC) contractor, following an agreed review.
The agreement also incorporates Heads of Terms in relation to PHE acting as operational process engineering supplier for the DMG?? Technology at the Protos site, encompassing design rights, build contracts and licensing proposition of its technology.
This contract comprises another step towards achieving Financial Close for the first commercial site utilising PHE???s DMG Technology.
David Ryan, CEO of PowerHouse Energy, commented:
???This is the first revenue generating contract signed by PHE and follows the typical revenue regime we will be following for future developments, recognising that more substantial revenues will arise from IP, Design Rights, and licensing and operational engineering in due course. This agreement demonstrates that W2T expects that a special purpose vehicle formed by it intends to place a formal order for DMG?? when the Pre-FEED and FEED work is complete. We thank W2T for their commitment and long standing support.???
John Hall, Chairman of Waste2Tricity (Protos) Limited commented:
???This agreement formalises our commitment to implement DMG?? Technology on the Protos site. We are working closely in partnership with Peel Environmental, the overall Protos Energy Hub site owners, to finalise all the design parameters with PHE to take the development to the FEED stage and through to fabrication and construction as soon as practical.???
David Ryan, CEO of PowerHouse Energy, further commented:
???We have delivered this agreement in line with our expectations this quarter and we are thankful to our shareholders who have supported us over the years to develop this ground breaking technology to this point of commercialisation and revenues.
ENDS
For more information, contact:
PowerHouse Energy Group plc Tel: +44 (0) 203 368 6399
David Ryan, Chief Executive Officer
WH Ireland Limited (Nominated Adviser) Tel: +44 (0) 207 220 1666
James Joyce / Chris Viggor
Turner Pope Investments Ltd (Joint Broker) Tel: +44 (0) 203 621 4120
Ben Turner / James Pope
Ikon Associates (Media enquiries) Tel: +44 (0) 1483 271291
Adrian Shaw Mob: +44 (0) 7979 900733
Notes for editors:
About PowerHouse Energy and DMG technology
PowerHouse Energy has developed a proprietary process technology – DMG?? – which can utilise waste plastic, end-of-life-tyres, and other waste streams to efficiently and economically convert them into syngas from which valuable products such as chemical precursors, hydrogen, electricity and other industrial products may be derived. The PowerHouse technology is one of the world???s first proven, modular, hydrogen from waste (HfW) process.
The PowerHouse DMG?? process can generate in excess of 1 tonne of road-fuel quality H2, and more than 28MW/h of exportable electricity per day.
The PowerHouse process produces low levels of safe residues and requires a small operating footprint, making it suitable for deployment at enterprise and community level.
PowerHouse is quoted on the London Stock Exchange's AIM Market under the ticker: PHE, and is incorporated in the United Kingdom.
For more information see www.powerhouseenergy.net
About Waste2Tricity (Protos) Limited
Waste2Tricity (Protos) Limited (W2TP) is the SPV (Special Purpose Vehicle) for the implementation of energy-from-waste facilities at the Protos site and has been set up by W2T the development partners of PHE.
Waste2Tricity is a structured solutions provider to the energy-from-waste (EfW) sector, an industry supplying increasing amounts of electricity using feedstock diverted from landfill.
Waste2Tricity works with clients and partners to develop, fund and support EfW deployment projects that use proven technology, are profitable and progressive; projects that currently use high temperature gasification and either steam cycle or internal combustion engines/gas turbines (ICEs/GTs) to efficiently convert waste to energy.
For more information see www.waste2tricity.com
About Peel Environmental and Protos
Peel Environmental, part of Peel Land and Property (Peel L&P), owns and develops waste infrastructure projects. It has achieved consent for a range of energy infrastructure schemes including a 35MW Energy from Waste plant at Protos in Cheshire, 21MW Energy from Waste plant and 250,000tpa AD and MRF in Glasgow; and a 20MW Energy Centre at Houghton Main, Barnsley. Peel works with investors, waste management companies, technology providers and contractors to secure a deliverable business model for each project.
Peel Environmental brought forward and consented the Protos development, previously known as Ince Resource Recovery Park. Protos is the destination of choice for energy, innovation and industry. Boasting unrivalled connections to some of the region???s biggest industrial forces, Protos is a strategic energy hub at the core of the Northern Powerhouse.
The 54ha (134 acres) development site has full outline planning consent and part detailed planning consent for general manufacturing and distribution uses (B1, B2 & B8), as well as a biomass facility and an Energy from Waste facility. Set on the south bank of the Manchester Ship Canal in the North West of England, the site is ideally placed to become an industrial micro-climate, with enviable transport links providing access to UK and International markets and surrounding industrial heartland.
For more information about Protos visit: www.thisisprotos.com
CloseOnline Blockchain : Corporate update
RNS Number : 3888W Online Blockchain PLC 17 April 2019 For immediate release 17 April 2019 Online Blockchain PLC ("Online" or the "Company") Corporate update New blockchain-based PC gaming product As announced in the recent interim results, Online Blockchain plc (LSE: OBC), a UK blockchain company, has……
RNS Number : 3888W
Online Blockchain PLC
17 April 2019
For immediate release
17 April 2019
Online Blockchain PLC
("Online" or the "Company")
Corporate update
New blockchain-based PC gaming product
As announced in the recent interim results, Online Blockchain plc (LSE: OBC), a UK blockchain company, has been developing new blockchain-based products and is now pleased to announce the first of these, FreeLoadr, a PC gaming product now in "invite-only" beta testing.
FreeLoadr (www.freeloadr.com), is an application for computer games which allows gamers access to PC games for no charge in exchange for running the FreeLoadr application on their personal computer (PC). The user donates "hash power" to earn points, which can then be redeemed for products on the store selection of 2,500 titles. FreeLoadr already has a large 'user waiting list' from its closed beta testing phase.
The FreeLoadr application currently supports computers with an NVIDIA graphics processing unit (GPU). On downloading and running the FreeLoadr application, the user exchanges unused graphic computing power to earn FreeLoadr points. The more powerful the user's PC, the quicker FreeLoadr points can be earned. The Company plans to develop FreeLoadr for crossover into Playstation & Xbox formats.
In an exchange of graphics power for points, FreeLoadr uses the donated GPU processing power to mine selected cryptocurrency (with receipts converted by FreeLoadr into fiat currency) and rewards each user with FreeLoadr points. When a FreeLoadr user has earned enough points, they can then be redeemed at no extra cost to the user in the FreeLoadr on-line store, which contains in excess of 2,500 Steam and Origin games (including Anthem and DragonBall FighterZ). The user selects a game title and is then sent an activation code which unlocks the chosen game.
OBC are now finalising the last stage of the Beta testing phase of FreeLoadr and plans to launch the product in the UK and North America.
Clem Chambers, CEO of Online said:
"Gaming is a valuable and exciting market. OBC had identified this opportunity in the market last year and now we are ready to showcase our products. With more than 2.2 billion active gamers in the world, the UK gaming sector generated revenue of £3.864bn in 2018, making it larger than music and video combined: Revenue from digital gaming in 2018 accounted for 80% of the UK Digital Games market. Globally the video games industry, in 2018, generated approximately US$135bn. (See "Sources" below)."
"We want to use the power of the blockchain to add value to PC gamers and make it possible for them to get the computer game they want using the latent but unused processing power of their PC. FreeLoadr makes this possible for the current generation of gaming computers without the user needing to be a blockchain or programming expert – they just need to download the FreeLoadr software and run it and they are on their way to getting their first game."
"Gaming is a fertile and welcoming sector for applications of new technology such as blockchain because gamers are tech-savvy. We believe that computer gaming is a compelling market application for blockchain, that FreeLoadr is an exciting product for both blockchain and computer gaming and we are delighted with its progress."
The number of FreeLoadr reward points needed to redeem a game is calculated by FreeLoadr to be equivalent to the game's retail price (based on the value of the cryptocurrency generated by the respective user's GPU). FreeLoadr pays the wholesale price to Steam and Origin for any game downloaded with points redeemed from the FreeLoadr store.
Shareholders should note that the development of FreeLoadr is in beta testing stage of development and launch, and further updates will be provided in due course. For further details go to: www.freeloadr.com.
A copy of this announcement is available on the Company's website at: www.onlineblockchain.io.
The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. The person who arranged for the release of this announcement on behalf of the Company was Clement Chambers, Director.
Enquiries:
For further information please contact:
|
Online Blockchain PLC Clement Chambers
|
+44 (0) 207 070 0909 |
|
|
|
|
Beaumont Cornish Limited (Nominated Adviser) |
+44 (0) 207 628 3396 |
|
Roland Cornish/Michael Cornish
|
|
|
Smaller Company Capital Limited (Broker) Jeremy Woodgate
|
+44 (0) 203 651 2910 |
|
|
|
|
Cassiopeia Ltd (Investor Relations) Stefania Barbaglio |
About Online Blockchain plc (LSE: OBC)
Online Blockchain (www.onlineblockchain.io) is a UK-based incubator and developer of businesses in internet and information-based technologies, including developers, administrators and custodians of blockchains and cryptocurrencies. The Company created ADVFN www.advfn.com and today still has a holding of 17.98% in ADVFN plc.
Online Blockchain plc continues to consider new related opportunities and particularly crypto currencies and blockchain-based opportunities including incubating cryptocurrency start-ups and developing technical innovation in the blockchain space. Led by a team with over two decades of pioneering in tech, Online Blockchain focuses on innovation in cryptocurrency and decentralised ecosystems via various applications of blockchain: incubating cryptocurrency start-ups and developing technical innovation in the blockchain space.
Glossary
"blockchain" is a distributed public digital ledger in which transactions are recorded chronologically
"cryptocurrency" is a digital currency in which encryption techniques are used to regulate the generation of units of currency and verify the transfer of funds, operating independently of any central bank
"Hash power" The speed at which a given mining machine operates.
"mining" is the process of using computer hardware to do mathematical calculations for a cryptocurrency network in order to confirm transactions. Miners collect transaction fees for the transactions they confirm and are awarded cryptocurrency for each block they verify
Sources:
The selected video games industry data contained in this announcement has been extracted from the following public sources:
https://news.sky.com/story/gaming-sector-now-larger-than-video-and-music-combined-11597476
ENDS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
UPDXQLFFKZFEBBL
Close
Neville Registrars Limited, Neville House, Steelpark Road, Halesowen, B62 8HD
Tel: 0121 585 1131
Email: info@nevilleregistrars.co.uk

© Neville Registrars Limited 2026. All Rights Reserved. Registered in England No. 4770411
